Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk prostate cancer

by Rafael Gadia, MD, Elton Trigo Teixeira Leite, MD, Ana Luiza Bierrenbach, PhD, Fabio Ynoe de Moraes, MD, Daniel E. Spratt, MD, Fernando Freire Arruda, MD, Carlos Eduardo Cintra Vita Abreu, MD, Joao Luis Fernandes da Silva, MD, Heloisa de Andrade Carvalho, PhD, Bernardo Garicochea, PhD
Published 2016-10-01

The Special Medical Physics Consult Process for Reirradiation Patients

by Kelly C. Paradis, PhD, Charles Mayo, PhD, Dawn Owen, MD, Daniel E. Spratt, MD, Jason Hearn, MD, Benjamin Rosen, PhD, Rojano Kashani, PhD, Jean Moran, PhD, Daniel S. Tatro, CMD, Whitney Beeler, MD, Karen Vineberg, CMD, Dylan C. Smith, MS, Martha M. Matuszak, PhD
Published 2019-10-01

Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19

by Nicholas G. Zaorsky, MD, James B. Yu, MD, Sean M. McBride, MD, Robert T. Dess, MD, William C. Jackson, MD, Brandon A. Mahal, MD, Ronald Chen, MD, Ananya Choudhury, MD, Ann Henry, MD, Isabel Syndikus, MD, Timur Mitin, MD, Alison Tree, MD, Amar U. Kishan, MD, Daniel E. Spratt, MD
Published 2020-11-01